SYMBIOSIS CAPITAL PARTNERS, LLC

PrivateCIK: 2006045
Location

BENTONVILLE, AR

📋 What this filing means

SYMBIOSIS CAPITAL PARTNERS, LLC filed this quarterly 13F‑HR report disclosing 6 equity positions with a total reported market value of $52.77M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.

6
Positions
$52.77M
Total AUM (reported)
8.63M
Total Shares

Allocation by class

TOTAL AUM$52.77M6 positions
COM SHS$29.45M55.8%
ADS$13.06M24.8%
SHS$5.44M10.3%
COM CL A$2.69M5.1%
COM NEW$2.13M4.0%
*W EXP 08/01/203$2.4K0.0%

Portfolio Concentration

Top 390.9%4–109.1%TOP 10100.0%0%100%
Top 3$47.95M90.9%
4–10$4.82M9.1%

Top 3 weight

90.9%

Top 10 weight

100.0%

Voting Authority Distribution

Total shares with voting rights: 8.63M

Sole

Full voting authority

8.63M

shares

% of voting shares100.0%
Shared

Joint voting authority

0.00

shares

% of voting shares0.0%
None

No voting authority

0.00

shares

% of voting shares0.0%

Investment Discretion (by position count)

Sole6
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings6
Rows:

Evommune, Inc.

SOLE
COM SHS
Shares1.28M
TypeSH
Market value$29.45M
55.80%
Sole
1.28M
Shared
0.00
None
0.00

Inventiva S.A.

SOLE
ADS
Shares2.35M
TypeSH
Market value$13.06M
24.76%
Sole
2.35M
Shared
0.00
None
0.00

Wave Life Sciences Ltd.

SOLE
SHS
Shares750K
TypeSH
Market value$5.44M
10.30%
Sole
750K
Shared
0.00
None
0.00

Rani Therapeutics Holdings, Inc.

SOLE
COM CL A
Shares3.67M
TypeSH
Market value$2.69M
5.11%
Sole
3.67M
Shared
0.00
None
0.00

Clene Nanomedicine Inc.

SOLE
COM NEW
Shares431.09K
TypeSH
Market value$2.13M
4.03%
Sole
431.09K
Shared
0.00
None
0.00

Surrozen, Inc.

SOLE
*W EXP 08/01/203
Shares150K
TypeSH
Market value$2.4K
<0.01%
Sole
150K
Shared
0.00
None
0.00
SYMBIOSIS CAPITAL PARTNERS, LLC 13F Holdings — 6 Positions | Finecho